Home > Healthcare > Pharmaceuticals > Finished Drug Form > Blood Platelets Market
Blood Platelets Market Size
- Report ID: GMI2849
- Published Date: May 2023
- Report Format: PDF
Blood Platelets Market Size
Blood Platelets Market size was valued at USD 5.2 billion in 2022 and is estimated to reach USD 7.7 billion by 2032. The increasing prevalence of chronic & blood related disorders across the globe is anticipated to drive the market revenue.
For instance, as per the American Journal of Managed Care, in 2020, a meta-analysis showed that over 1,125,000 men around the world were suffering from an inherited bleeding disorder. According to the National Center for Biotechnology Information recent research article, around 1 in 3 of all adults suffer from multiple chronic conditions (MCCs) globally. These statistics are expected to augment the blood transfusion demand in the coming years positively.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Blood Platelets Market Size in 2022: | USD 5.2 billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.5% |
| 2032 Value Projection: | USD 7.7 billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 204 |
| Tables, Charts & Figures: | 269 |
| Segments covered: | Platelet Type, Application, End-use and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Additionally, the several health concerns associated with these ailments are anticipated to stimulate the adoption of blood platelets for the effective management of these disease conditions. Moreover, rising awareness regarding chronic & blood related diseases, early-stage disease diagnosis & treatment, and a surging number of healthcare settings are set to prove conducive for business growth.
Blood platelets are colourless blood cells that help in blood clotting and further assist in stopping the bleeding by clumping and forming plugs in blood vessel injuries. However, high risk of transmission of blood transfusion associated infections may negatively impact the blood platelets market progress. Blood and blood products can result in considerable adverse events involving inefficacy, immunologic reactions, infections, and others that can result in death & critical disability. Bacterial contamination of blood products, especially in platelets that are stored at room temperature, is the most common infectious risk of blood transfusion.
Transfusion–transmitted sepsis, a persistent problem in transfusion can cause serious infection & death. In low-income countries, the risk for transfusion-transmitted human immunodeficiency virus (HIV) is high attributable to lower blood screening testing in hospitals and blood banks. Hence, blood transfusion has been and continues to be a possible source of disease transmission. However, enhanced donor screening as well as improved practices of collection, handling, and storing of blood products has reduced bacterial contamination in recent years.
Frequently Asked Questions (FAQ) :
Blood Platelets Market Scope
